Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Nanoliposomal delivery of cytosolic phospholipase A2 inhibitor arachidonyl trimethyl ketone for melanoma treatment.

Gowda R, Dinavahi SS, Iyer S, Banerjee S, Neves RI, Pameijer CR, Robertson GP.

Nanomedicine. 2018 Apr;14(3):863-873. doi: 10.1016/j.nano.2017.12.020. Epub 2018 Jan 6.

PMID:
29317343
2.

Moving Synergistically Acting Drug Combinations to the Clinic by Comparing Sequential versus Simultaneous Drug Administrations.

Dinavahi SS, Noory MA, Gowda R, Drabick JJ, Berg A, Neves RI, Robertson GP.

Mol Pharmacol. 2018 Mar;93(3):190-196. doi: 10.1124/mol.117.110759. Epub 2017 Dec 14.

PMID:
29242354
3.

Improving pharmacological targeting of AKT in melanoma.

Kuzu OF, Gowda R, Sharma A, Noory MA, Dinavahi SS, Kardos G, Drabick JJ, Robertson GP.

Cancer Lett. 2017 Sep 28;404:29-36. doi: 10.1016/j.canlet.2017.07.001. Epub 2017 Jul 11.

PMID:
28705772
4.

Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport.

Gowda R, Inamdar GS, Kuzu O, Dinavahi SS, Krzeminski J, Battu MB, Voleti SR, Amin S, Robertson GP.

Oncotarget. 2017 Apr 25;8(17):28260-28277. doi: 10.18632/oncotarget.16002.

5.

A Novel, Potent, Small Molecule AKT Inhibitor Exhibits Efficacy against Lung Cancer Cells In Vitro.

Dinavahi SS, Prasanna R, Dharmarajan S, Perumal Y, Viswanadha S.

Cancer Res Treat. 2015 Oct;47(4):913-20. doi: 10.4143/crt.2014.057. Epub 2015 Jan 2.

6.

Combined inhibition of PDE4 and PI3Kδ modulates the inflammatory component involved in the progression of chronic obstructive pulmonary disease.

Dinavahi SS, Nyayapathy S, Perumal Y, Dharmarajan S, Viswanadha S.

Drug Res (Stuttg). 2014 Apr;64(4):214-9. doi: 10.1055/s-0033-1355411. Epub 2013 Oct 8.

PMID:
24105104

Supplemental Content

Loading ...
Support Center